{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ05236",
      "entity_text" : "JEV NS5",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q13216",
      "entity_text" : "CsA",
      "entity_type" : "protein"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "Combined treatment with CsA and IFNbeta reduced Type I IFN antagonistic activity of JEV NS5; we hypothesized calcineurin involvement in NS5 induced IFNbeta antagonism on STAT1 mediated signaling pathway.",
  "reading_complete" : "2020-08-08T14:52:41Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T14:48:29Z",
  "trigger" : "reduced",
  "evidence" : [ "CsA and IFNbeta reduced Type I IFN antagonistic activity of JEV NS5" ],
  "pmc_id" : "7167617",
  "score" : 0
}